Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta Sells 23,416 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) COO Amit Gupta sold 23,416 shares of Cardlytics stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now owns 122,676 shares of the company’s stock, valued at approximately $1,461,071.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Cardlytics Stock Performance

CDLX stock opened at $11.52 on Thursday. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31. The company has a 50 day moving average price of $11.10 and a 200 day moving average price of $9.64. Cardlytics, Inc. has a fifty-two week low of $4.94 and a fifty-two week high of $20.52. The stock has a market capitalization of $554.96 million, a PE ratio of -3.33 and a beta of 1.44.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) earnings per share for the quarter. Cardlytics had a negative return on equity of 25.38% and a negative net margin of 43.56%. The company had revenue of $89.17 million during the quarter.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of CDLX. Tower Research Capital LLC TRC grew its holdings in Cardlytics by 349.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 9,602 shares of the company’s stock worth $88,000 after acquiring an additional 7,465 shares during the period. D L Carlson Investment Group Inc. acquired a new stake in Cardlytics during the 3rd quarter worth $173,000. New York State Common Retirement Fund grew its holdings in Cardlytics by 600.8% during the 3rd quarter. New York State Common Retirement Fund now owns 13,498 shares of the company’s stock worth $223,000 after acquiring an additional 11,572 shares during the period. Shikiar Asset Management Inc. acquired a new stake in Cardlytics during the 3rd quarter worth $247,000. Finally, SG Americas Securities LLC acquired a new stake in Cardlytics during the 3rd quarter worth $264,000. Institutional investors own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CDLX shares. Needham & Company LLC lifted their target price on shares of Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, April 9th. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “buy” rating and lifted their target price for the company from $10.00 to $18.00 in a research note on Friday, March 15th. Finally, Lake Street Capital lifted their target price on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, March 15th.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.